A Clinical Trial to Evaluate the Effects of Broc Shot Capsules on Skin Appearance and Comfort in Adults With Reactive, Blemish-Prone, or Hormonally Affected Skin
This is a randomized, double-blind, placebo-controlled, fully decentralized (remote) clinical trial evaluating the effects of Broc Shot Capsules on skin appearance and comfort in adults with reactive, blemish-prone, or hormonally affected skin. Fifty participants aged 18-65 years will be randomly assigned in a 1:1 ratio to receive either Broc Shot Capsules (active) or matched placebo capsules for 8 weeks.
Participants will take 2 capsules once daily and complete self-reported questionnaires and standardized self-captured skin photographs at Baseline, Week 4, and Week 8 via a secure online study platform. Expert dermatologist grading of photographs will be conducted remotely at each timepoint. The study is designed to substantiate consumer product claims related to visible skin improvement and participant-reported skin comfort, and is not intended to evaluate treatment of any clinical dermatological disease.
調査の概要
状態
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前:Gracia Walker
- メール:gracia@brocshot.com
研究場所
-
-
Nevada
-
Las Vegas、Nevada、アメリカ、89101
- Citruslabs
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
説明
Inclusion Criteria:
- Adults aged 18 to 65 years (inclusive) at the time of consent.
- Self-reported skin concerns matching at least one of the following descriptions: I have red, itchy skin patches
- I have dry, flaky/scaley skin patches
- my skin has blemishes such as pimples, discoloured papules (small, tender bumps that are pink/red/purple/or darker than your natural skin tone) or pustules (a distinct white or yellow pus-filled center surrounded by a red base).
- Generally healthy adults who are willing and able to follow the study protocol for the full 8-week duration, including taking 2 capsules of the study product once daily for 8 consecutive weeks without skipping days, answering questionnaires at Baseline, Week 4, and Week 8, and following the photograph submission protocol at Baseline, Week 4, and Week 8.
- Willing to avoid initiating any new topical or oral skincare products, prescription medications targeting skin, or other dietary supplements specifically marketed for skin benefit during the study period.
- Participants currently using such products who have been using them consistently for at least 3 months prior to enrollment and are willing to continue unchanged throughout the study are eligible.
- Willing to maintain their current diet, lifestyle, sleep pattern, sun exposure habits, and skincare routine for the duration of the trial.
- Resides within the United States.
- Access to a smartphone or computer with internet connection and the ability to use the Citruslabs digital study platform.
Exclusion Criteria:
- Known allergy, hypersensitivity, or intolerance to broccoli, horseradish, other cruciferous vegetables (Brassicaceae family), or any component of the study product or placebo capsule.
- Currently pregnant, breastfeeding, or planning to become pregnant during the study period.
- Currently taking prescription anticoagulant medications (e.g., warfarin, apixaban, rivaroxaban) due to the potential for product ingredients to interact with anticoagulant activity.
- History of a severe or unstable medical condition that, in the opinion of the study team, would prevent safe participation or adherence to the protocol, including active cancer treatment.
- Currently using any oral, topical, or biologic prescription medication specifically indicated for a diagnosed dermatological condition, unless the regimen has been stable for at least 3 months and no changes are planned during the study period.
- Planned dermatological procedures during the study period (e.g., chemical peels, laser treatments, microneedling, injectable cosmetic procedures) that could confound skin appearance assessments.
- Currently enrolled in another clinical or consumer research study, or plans to enroll in any such study during the 8-week study period.
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:処理
- 割り当て:ランダム化
- 介入モデル:並列代入
- マスキング:ダブル
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
プラセボコンパレーター:プラセボコンパレーター
|
Participants will take 2 capsules once daily, with their first meal of the day, avoiding administration with hot or acidic liquids. |
|
実験的:BrocShot Collagen
|
Participants will take 2 capsules once daily, with their first meal of the day, avoiding administration with hot or acidic liquids. |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Clinician-Assessed Change in Overall Skin Appearance
時間枠:Baseline to Week 8
|
Change from Baseline in overall skin appearance graded by a qualified dermatologist reviewing participant-submitted digital photographs using a binary Yes/No improvement scale assessing overall skin health, pigmentation, dryness, brightness, scarring, blemishes, redness, and flaking |
Baseline to Week 8
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Participant-Reported Change in Skin Appearance
時間枠:Baseline, Week 4, and Week 8
|
Change from Baseline in self-reported skin appearance assessed via a participant-reported skin questionnaire |
Baseline, Week 4, and Week 8
|
|
Participant-Reported Change in Skin Clarity
時間枠:Baseline, Week 4, and Week 8
|
Change from Baseline in self-reported skin clarity assessed via a participant-reported skin questionnaire |
Baseline, Week 4, and Week 8
|
|
Participant-Reported Change in Skin Calmness
時間枠:Baseline, Week 4, and Week 8
|
Change from Baseline in self-reported skin calmness assessed via a participant-reported skin questionnaire |
Baseline, Week 4, and Week 8
|
|
Participant-Reported Change in Visible Skin Concerns
時間枠:Baseline, Week 4, and Week 8
|
Change from Baseline in self-reported visible skin concerns assessed via a participant-reported skin questionnaire |
Baseline, Week 4, and Week 8
|
|
Participant-Reported Change in Skin Texture
時間枠:Baseline, Week 4, and Week 8
|
Change from Baseline in self-reported skin texture assessed via a participant-reported skin questionnaire |
Baseline, Week 4, and Week 8
|
|
Participant-Reported Change in Skin Luminosity
時間枠:Baseline, Week 4, and Week 8
|
Change from Baseline in self-reported skin luminosity assessed via a participant-reported skin questionnaire |
Baseline, Week 4, and Week 8
|
|
Participant-Reported Change in Skin Age Appearance
時間枠:Baseline, Week 4, and Week 8
|
Change from Baseline in self-reported skin age appearance assessed via a participant-reported skin questionnaire |
Baseline, Week 4, and Week 8
|
|
Participant-Reported Change in Itching and Irritation
時間枠:Baseline, Week 4, and Week 8
|
Change from Baseline in self-reported itching and irritation assessed via a participant-reported skin questionnaire |
Baseline, Week 4, and Week 8
|
|
Participant-Reported Change in Skin Comfort
時間枠:Baseline, Week 4, and Week 8
|
Change from Baseline in self-reported skin comfort assessed via a participant-reported skin questionnaire |
Baseline, Week 4, and Week 8
|
|
Participant-Reported Change in Skin Confidence
時間枠:Baseline, Week 4, and Week 8
|
Change from Baseline in self-reported skin confidence assessed via a participant-reported skin questionnaire |
Baseline, Week 4, and Week 8
|
協力者と研究者
スポンサー
協力者
研究記録日
主要日程の研究
研究開始 (推定)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。